Hugel, a global pharmaceutical company, received FDA approval for their new botulinum toxin, Letybo, marking a milestone in aesthetic medicine. Letybo offers a new option for anti-aging treatments, catering to physicians and patients seeking innovative solutions in the realm of non-surgical aesthetics. This development signifies progress in enhancing natural beauty, shaping the future of aesthetic medicine.

Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:

🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights

👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!

#AIAutomationMinute #DrTeriFisher #HealthcareAI